Esomeprazole Magnesium Capsule, Delayed Release
Product Images NDC 51407-742

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Esomeprazole Magnesium (NDC 51407-742). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51407-742-10ol (Esomeprazole Magnesium 20 mg)

51407-742-10ol (Esomeprazole Magnesium 20 mg)
This text contains information about Esomeprazole Magnesium Delayed-Release Capsules. Each capsule contains 20 mg of esomeprazole. It advises the pharmacist to dispense the Medication Guide to each patient and includes dosage instructions and storage guidelines. The product is not intended for household use and should be kept out of the reach of children. The medication should be stored at 20-25°C. The product is marketed by GSMS, Incorporated in Camarillo, CA.*
FDA Label Image

51407-743-10ol (Esomeprazole Magnesium 40 mg)

51407-743-10ol (Esomeprazole Magnesium 40 mg)
This is a description of Esomeprazole Magnesium Delayed-Release Capsules, USP. The capsules contain 40 mg of esomeprazole each and come in a pack of 1,000 capsules. The usual adult dosage should be checked in the package insert. The medication should be kept out of children's reach, in a tightly closed container, and stored at 20-25°C. The medication is not intended for household use and is to be distributed with a Medication Guide to each patient. It is marketed by GSMS, Incorporated in Camarillo, CA, USA.*
FDA Label Image

Spl-figure-2 (Spl Figure 2)

Spl-figure-2 (Spl Figure 2)
This text includes information on different dosages of Esomeprazole Magnesium (10 mg, 20 mg, and 40 mg) as well as a placebo for a study with a total of 245 participants. The study likely involved scheduled visits for the participants.*
FDA Label Image

Spl-figure-3 (Spl Figure 3)

FDA Label Image

Spl-figure-4 (Spl Figure 4)

FDA Label Image

Spl-figure-5 (Spl Figure 5)

FDA Label Image

Spl-structure (Spl Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.